Aggressive buybacks are giving some companies an edge, Jim Cramer says
[ad_1] As buybacks slow across the market, CNBC’s Jim Cramer on Tuesday told investors why he thinks generous share repurchasing…
Author: Trade r edarT
Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.
[ad_1] President Donald Trump’s administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with…
What’s likely to move the market in the next trading session
[ad_1] Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last…
The Democrats Very Much Need a Reset On the Economy
[ad_1] Democrats are facing a crisis of credibility on the economy. A visit to the grocery store, even the price…
Reuters Tankan: Japan manufacturers at 3-year peak, services rebound to +27
[ad_1] Japanese manufacturers’ confidence climbed to its strongest level in more than three years in September, supported by easing trade…
XRP Rally To $3.60 Must Include More Than ETF Approval
[ad_1] Key takeaways: Bloomberg analysts assign 95% odds for an XRP ETF, with a SEC decision expected for October. XRPL…
Nakamoto commits $30M to Metaplanet in largest investment and Asian market entry
[ad_1] Key Takeaways Nakamoto has made its largest single investment, committing $30 million to Metaplanet. This investment marks Nakamoto’s first…
Markets digest report of BoJ’s undeterred hawkishness – Scotiabank
[ad_1] The Japanese Yen (JPY) is strong, up 0.7% against the US Dollar (USD) and outperforming all of the G10…
Biotech Stocks Under $5, 200%+ Upside Potential
[ad_1] Investing in biotechnology stocks is typically reserved for speculative investors. For starters, many of these companies are clinical or…
Trump signs memo to crack down on direct-to-consumer pharma ads
[ad_1] U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President…